Managing type 2 diabetes: targeting a microbial enzyme as a novel treatment option
Open Access
- 6 December 2023
- journal article
- editorial
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 8 (1) , 1-3
Abstract
No abstract availableKeywords
Funding Information
- Országos Tudományos Kutatási Alapprogramok (K132439)
This publication has 5 references indexed in Scilit:
- Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic targetScience, 2023
- Chemoproteomic identification of a DPP4 homolog in Bacteroides thetaiotaomicronNature Chemical Biology, 2023
- Extracellular vesicles produced by the human commensal gut bacterium Bacteroides thetaiotaomicron affect host immune pathways in a cell‐type specific manner that are altered in inflammatory bowel diseaseJournal of Extracellular Vesicles, 2022
- Insulin Resistance and Cardiometabolic Risk Profile Among Nondiabetic American Young Adults: Insights From NHANESThe Journal of Clinical Endocrinology & Metabolism, 2021
- StatPearls2019